March 9 (Reuters) - AGFA GEVAERT NV AGFB.BR :
* GROUP TOPLINE 3% ABOVE 2020, WITH CONTRASTED DIVISIONAL
PERFORMANCES
* FY ADJUSTED EBITDA 5% ABOVE 2020
* STRONG PROFITABILITY PERFORMANCE OF HEALTHCARE IT
* FY WORKING CAPITAL DECREASED TO 26% OF SALES DESPITE RAW
MATERIAL COST INFLATION AND SUPPLY CHAIN ISSUES
* GROUP EXPECTS THAT UNCERTAINTY IN MOST OF ITS MARKETS WILL
CONTINUE WELL INTO 2022.
* FY REVENUE EUR 1.76 BILLION VERSUS EUR 1.71 BILLION YEAR
AGO
* HOWEVER, FOR FULL YEAR 2022, ALL DIVISIONS ARE EXPECTED TO
GROW
THEIR TOP LINE
* FY NET LOSS OF 14 MILLION EURO
* FOR HEALTHCARE IT DIVISION, 2022 WILL BE A YEAR OF
CONSOLIDATION
* IN 2021, GROUP GENERATED A FREE CASH FLOW OF 8 MILLION
EURO,
BEFORE EXTRA PENSION FUNDING OF 130 MILLION EURO
* ONGOING TRANSFORMATION ACTIONS ARE EXPECTED TO BRING MORE
AGILITY AND TO FURTHER SIMPLIFY OPERATIONS OF GROUP
* THEY WILL ALSO ALLOW GROUP TO FURTHER REDUCE ITS COSTS
FROM 2023
ONWARDS
* MORE RECENTLY, UKRAINE CRISIS CREATES NEW UNCERTAINTIES
GROUP IS
ASSESSING
Source text for Eikon: urn:newsml:reuters.com:*:nGNE3K3nxH
Further company coverage: AGFB.BR
(Gdansk Newsroom)
((Gdansk.newsroom@thomsonreuters.com; +48 58 772 09 20;))